Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2055 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Azithromycin is an antibiotic currently prescribed continuously in cystic fibrosis patients. It was shown that this treatment taken every day or every week for 12 months, can improve the respiratory state of patients. From the second year of treatment, it would appear there is more profit to continue such treatment.

The main objective is to study the association between continuous use of azithromycin and lung function measured by Forced expiratory volume in one second (FEV1), after two years of treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa

NCT00431964

Cystic Fibrosis

COMPLETED PHASE4

Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

NCT02372383

Cystic Fibrosis

COMPLETED NA

Prevention of Bronchiectasis in Infants With Cystic Fibrosis

NCT01270074

Cystic Fibrosis Bronchiectasis

COMPLETED PHASE3

Effect of Azithromycin on Fatty Acids in CF

NCT03045198

Cystic Fibrosis

UNKNOWN PHASE4

Scandinavian Cystic Fibrosis Azithromycin Study

NCT00411736

Cystic Fibrosis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystic Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cystic fibrosis patients taking azithromycin

Cystic fibrosis patients taking azithromycin continuously for two years.

Azithromycin

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Azithromycin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with Cystic Fibrosis (whatever the genetic form)
* Age ≥ 8 years
* FEV ≥ 30% the year of azithromycin (N0)
* Continuous treatment with azithromycin for at least 2 years.